Certified Information Security Manager CISM Practice Test 13
Question 120
Remediation is reported complete, but no retest confirms residual exposure within the agreed limits. The team proposes to retest the controls and obtain authorized acceptance of any residual risk. Who should authorize that decision within documented business and security limits?
- The technical control operator because that role implements the approved configuration — using technical implementation responsibility as approval authority for residual risk measurement.
- The service provider because its contract covers the infrastructure — using contractual delivery responsibility as approval authority for residual risk measurement.
- The independent assurance reviewer who will later test the control — using independent review duties as approval authority for residual risk measurement.
- The accountable business or information owner acting within delegated limits and advised by security and affected functions — for the decision to retest the controls and obtain authorized acceptance of any residual risk.
Explanation
Correct Answer
D:For residual risk measurement, the named accountable authority can balance business, security and legal consequences under its delegated mandate. Specialist staff implement or advise; material deviations require escalation. The decision also addresses the risk that untested provider controls cannot justify a reduction in the exposure accepted by the business.
Incorrect Answers
A:Access to technical systems does not automatically confer enterprise authority over residual risk measurement. The operator may recommend or execute a properly authorized decision but cannot unilaterally accept the business consequences.
B:Contractual delivery responsibility and technical expertise do not transfer the enterprise’s ultimate accountability for residual risk measurement. The responsible internal authority must approve consequential decisions.
C:Independent assurance should test and challenge the residual risk measurement decision, not ordinarily authorize the activity it will later evaluate. That would blur accountability and separation of duties.
Question 121
A sponsor wants to accept substantial expected losses without checking whether the sponsor has the delegated authority. What governance or response action addresses the stated gap?
- Map enterprise risk tolerance and delegated acceptance authority.
- Document an authorized, time-limited treatment with funding and conditions.
- Monitor response milestones and reopen decisions after material changes.
- Compare avoidance, mitigation, transfer and acceptance against service objectives.
Explanation
Correct Answer
A:Map enterprise risk tolerance and delegated acceptance authority. The scenario's unresolved need is delegated ownership, and this action produces an approved decision and escalation record for acceptance and treatment choice. That directly addresses the risk that a sponsor could accept loss beyond delegated limits without evaluating practical treatment alternatives.
Incorrect Answers
B:Document an authorized, time-limited treatment with funding and conditions is pertinent to implementation, but it depends on a still-missing delegated ownership decision or record. Applying it first would leave the current acceptance and treatment choice exposure unresolved, even if that later action is worthwhile.
C:Monitor response milestones and reopen decisions after material changes is pertinent to control assurance, but it depends on a still-missing delegated ownership decision or record. Applying it first would leave the current acceptance and treatment choice exposure unresolved, even if that later action is worthwhile.
D:Compare avoidance, mitigation, transfer and acceptance against service objectives is pertinent to risk evaluation, but it depends on a still-missing delegated ownership decision or record. Applying it first would leave the current acceptance and treatment choice exposure unresolved, even if that later action is worthwhile.
Question 122
A sponsor wants to accept substantial expected losses without checking whether the sponsor has the delegated authority. A director recommends: "Compare avoidance, mitigation, transfer and acceptance against service objectives." What response best addresses the evidence and decision authority in the case?
- Combine work to compare avoidance, mitigation, transfer and acceptance against service objectives and document an authorized, time-limited treatment with funding and conditions in a single funded milestone; document the decision to map enterprise risk tolerance and delegated acceptance authority for later closure.
- Address the unmet requirement to map enterprise risk tolerance and delegated acceptance authority, while separately coordinating urgent protective steps within approved authority.
- Authorize a bounded pilot to compare avoidance, mitigation, transfer and acceptance against service objectives, then use its results to determine whether the team still needs to map enterprise risk tolerance and delegated acceptance authority.
- Begin with the alternative action to document an authorized, time-limited treatment with funding and conditions and reassess whether the team still needs to map enterprise risk tolerance and delegated acceptance authority after observing outcomes.
Explanation
Correct Answer
B:This preserves the outstanding delegated ownership decision without treating compare avoidance, mitigation, transfer and acceptance against service objectives as inherently invalid. The immediate requirement is an approved decision and escalation record. Any urgent safety or containment action can continue if it is authorized under a separate response plan.
Incorrect Answers
A:Bundling treatment activities can be efficient, but funding two other actions does not show the named delegated ownership gap is resolved. The present management decision still needs a responsible owner and supporting evidence.
C:The proposal to compare avoidance, mitigation, transfer and acceptance against service objectives might be a useful pilot, but the case already identifies a missing delegated ownership requirement. A pilot cannot replace an approved decision and escalation record; it should be assessed only within authorized boundaries.
D:Document an authorized, time-limited treatment with funding and conditions can be useful in acceptance and treatment choice, but it does not eliminate the unmet requirement to map enterprise risk tolerance and delegated acceptance authority. The proposed order risks assessing the wrong outcome or missing accountable authorization for the case.
Question 123
A sponsor wants to accept substantial expected losses without checking whether the sponsor has the delegated authority. Which evidence should an independent reviewer seek to validate the current management decision?
- A signed exposure and control assessment informing the decision to compare avoidance, mitigation, transfer and acceptance against service objectives.
- Deployment and representative operating tests demonstrating the decision to document an authorized, time-limited treatment with funding and conditions was implemented.
- An approved responsibility and delegation record authorizing the decision to map enterprise risk tolerance and delegated acceptance authority.
- An assurance log of outcomes, exceptions and follow-up after the decision to monitor response milestones and reopen decisions after material changes.
Explanation
Correct Answer
C:An approved responsibility and delegation record authorizing the decision to map enterprise risk tolerance and delegated acceptance authority. It specifically verifies an approved decision and escalation record, the outstanding requirement in this case. This matters because a sponsor could accept loss beyond delegated limits without evaluating practical treatment alternatives and an assertion of compliance alone cannot show that the risk has been managed.
Incorrect Answers
A:This demonstrates a later risk evaluation objective, but it cannot substitute for the unresolved delegated ownership decision in the case. The evidence is valuable only when that prerequisite is met.
B:This demonstrates a later implementation objective, but it cannot substitute for the unresolved delegated ownership decision in the case. The evidence is valuable only when that prerequisite is met.
D:This demonstrates a later control assurance objective, but it cannot substitute for the unresolved delegated ownership decision in the case. The evidence is valuable only when that prerequisite is met.
Question 124
Delegations are verified, but the proposed acceptance has no comparison with avoidance, mitigation and transfer. An updated assessment raises concern that a sponsor could accept loss beyond delegated limits without evaluating practical treatment alternatives. Which response keeps the management decision current and accountable?
- Report delivery of the existing acceptance and treatment choice plan without reopening the previous risk assumptions.
- Continue the approved acceptance and treatment choice exception until its original expiry, keeping the existing acceptance decision.
- Let the delivery team revise the acceptance and treatment choice response immediately and seek management ratification afterward.
- Have the delegated risk owner reassess acceptance and treatment choice and update the treatment decision to compare avoidance, mitigation, transfer and acceptance against service objectives if new exposure exceeds tolerance.
Explanation
Correct Answer
D:Exposure and residual acceptance depend on current assumptions. A delegated owner must reassess the new evidence because a sponsor could accept loss beyond delegated limits without evaluating practical treatment alternatives. The evidence needed to compare avoidance, mitigation, transfer and acceptance against service objectives should be documented and escalated when the risk exceeds approved tolerance.
Incorrect Answers
A:Historical approvals and task counts do not show that the changed risk remains within tolerance. The new condition warrants a refreshed analysis and accountable response, not solely activity reporting.
B:An exception record is not a substitute for assessing the significance of the new evidence to acceptance and treatment choice. Earlier acceptance was conditional on facts that may no longer hold.
C:Urgent actions may be allowed within predelegated incident authority, but unilateral changes by implementers do not replace accountable reassessment and escalation when business impact changes.
Question 125
Delegations are verified, but the proposed acceptance has no comparison with avoidance, mitigation and transfer. The committee needs evidence about acceptance and treatment choice. Which deliverable would address the identified deficiency most directly?
- A management-endorsed assessment documenting the evidence needed to compare avoidance, mitigation, transfer and acceptance against service objectives for the outstanding impact assessment.
- A signed delegation and escalation record authorizing the organization to map enterprise risk tolerance and delegated acceptance authority for the outstanding impact assessment.
- A traceable deployment record and operating test confirming action to document an authorized, time-limited treatment with funding and conditions for the outstanding impact assessment.
- An assurance review and corrective-action record confirming results from a decision to monitor response milestones and reopen decisions after material changes for the outstanding impact assessment.
Explanation
Correct Answer
A:Compare avoidance, mitigation, transfer and acceptance against service objectives. The scenario's unresolved need is risk evaluation, and this action produces an evidence-backed assessment of consequences for acceptance and treatment choice. That directly addresses the risk that a sponsor could accept loss beyond delegated limits without evaluating practical treatment alternatives.
Incorrect Answers
B:Map enterprise risk tolerance and delegated acceptance authority is pertinent to delegated ownership, but the scenario already assumes that prerequisite is established. Repeating it does not provide an evidence-backed assessment of consequences now needed for acceptance and treatment choice.
C:Document an authorized, time-limited treatment with funding and conditions is pertinent to implementation, but it depends on a still-missing risk evaluation decision or record. Applying it first would leave the current acceptance and treatment choice exposure unresolved, even if that later action is worthwhile.
D:Monitor response milestones and reopen decisions after material changes is pertinent to control assurance, but it depends on a still-missing risk evaluation decision or record. Applying it first would leave the current acceptance and treatment choice exposure unresolved, even if that later action is worthwhile.
Question 126
The owner approved a bounded response; resources, exception conditions and implementation dates have not been recorded. Which artifact provides the most relevant proof of an effective response at this point?
- A control-performance review recording exceptions and corrections following work to monitor response milestones and reopen decisions after material changes.
- An accountable implementation sign-off and test result for the action to document an authorized, time-limited treatment with funding and conditions.
- A version-controlled delegation and escalation memo establishing the authority to map enterprise risk tolerance and delegated acceptance authority.
- A risk treatment justification with service impact evidence supporting the decision to compare avoidance, mitigation, transfer and acceptance against service objectives.
Explanation
Correct Answer
B:An accountable implementation sign-off and test result for the action to document an authorized, time-limited treatment with funding and conditions. It specifically verifies an implemented and tested treatment, the outstanding requirement in this case. This matters because a sponsor could accept loss beyond delegated limits without evaluating practical treatment alternatives and an assertion of compliance alone cannot show that the risk has been managed.
Incorrect Answers
A:This demonstrates a later control assurance objective, but it cannot substitute for the unresolved implementation decision in the case. The evidence is valuable only when that prerequisite is met.
C:This would document earlier delegated ownership, which the case has already established. It does not demonstrate an implemented and tested treatment required to resolve the current issue.
D:This would document earlier risk evaluation, which the case has already established. It does not demonstrate an implemented and tested treatment required to resolve the current issue.
Question 127
The owner approved a bounded response; resources, exception conditions and implementation dates have not been recorded. Which decision addresses the documented deficiency most directly?
- Reconfirm delegated approval to map enterprise risk tolerance and delegated acceptance authority.
- Revisit assessed exposure to compare avoidance, mitigation, transfer and acceptance against service objectives.
- Put the approved plan into operation to document an authorized, time-limited treatment with funding and conditions.
- Prepare an effectiveness review to monitor response milestones and reopen decisions after material changes.
Explanation
Correct Answer
C:Document an authorized, time-limited treatment with funding and conditions. The scenario's unresolved need is implementation, and this action produces an implemented and tested treatment for acceptance and treatment choice. That directly addresses the risk that a sponsor could accept loss beyond delegated limits without evaluating practical treatment alternatives.
Incorrect Answers
A:Map enterprise risk tolerance and delegated acceptance authority is pertinent to delegated ownership, but the scenario already assumes that prerequisite is established. Repeating it does not provide an implemented and tested treatment now needed for acceptance and treatment choice.
B:Compare avoidance, mitigation, transfer and acceptance against service objectives is pertinent to risk evaluation, but the scenario already assumes that prerequisite is established. Repeating it does not provide an implemented and tested treatment now needed for acceptance and treatment choice.
D:Monitor response milestones and reopen decisions after material changes is pertinent to control assurance, but it depends on a still-missing implementation decision or record. Applying it first would leave the current acceptance and treatment choice exposure unresolved, even if that later action is worthwhile.
Question 128
The owner approved a bounded response; resources, exception conditions and implementation dates have not been recorded. A director recommends: "Monitor response milestones and reopen decisions after material changes." What response best addresses the evidence and decision authority in the case?
- Begin with the alternative action to map enterprise risk tolerance and delegated acceptance authority and reassess whether the team still needs to document an authorized, time-limited treatment with funding and conditions after observing outcomes.
- Combine work to monitor response milestones and reopen decisions after material changes and map enterprise risk tolerance and delegated acceptance authority in a single funded milestone; document the decision to document an authorized, time-limited treatment with funding and conditions for later closure.
- Authorize a bounded pilot to monitor response milestones and reopen decisions after material changes, then use its results to determine whether the team still needs to document an authorized, time-limited treatment with funding and conditions.
- Address the unmet requirement to document an authorized, time-limited treatment with funding and conditions, while separately coordinating urgent protective steps within approved authority.
Explanation
Correct Answer
D:This preserves the outstanding implementation decision without treating monitor response milestones and reopen decisions after material changes as inherently invalid. The immediate requirement is an implemented and tested treatment. Any urgent safety or containment action can continue if it is authorized under a separate response plan.
Incorrect Answers
A:Map enterprise risk tolerance and delegated acceptance authority can be useful in acceptance and treatment choice, but it does not eliminate the unmet requirement to document an authorized, time-limited treatment with funding and conditions. The proposed order risks assessing the wrong outcome or missing accountable authorization for the case.
B:Bundling treatment activities can be efficient, but funding two other actions does not show the named implementation gap is resolved. The present management decision still needs a responsible owner and supporting evidence.
C:The proposal to monitor response milestones and reopen decisions after material changes might be a useful pilot, but the case already identifies a missing implementation requirement. A pilot cannot replace an implemented and tested treatment; it should be assessed only within authorized boundaries.
Question 129
An approved response has slipped past its target date, and new business operations have changed the risk assumptions. The team proposes to monitor response milestones and reopen decisions after material changes. Who should authorize that decision within documented business and security limits?
- The accountable business or information owner acting within delegated limits and advised by security and affected functions — for the decision to monitor response milestones and reopen decisions after material changes.
- The technical control operator because that role implements the approved configuration — using technical implementation responsibility as approval authority for acceptance and treatment choice.
- The service provider because its contract covers the infrastructure — using contractual delivery responsibility as approval authority for acceptance and treatment choice.
- The independent assurance reviewer who will later test the control — using independent review duties as approval authority for acceptance and treatment choice.
Explanation
Correct Answer
A:For acceptance and treatment choice, the named accountable authority can balance business, security and legal consequences under its delegated mandate. Specialist staff implement or advise; material deviations require escalation. The decision also addresses the risk that a sponsor could accept loss beyond delegated limits without evaluating practical treatment alternatives.
Incorrect Answers
B:Access to technical systems does not automatically confer enterprise authority over acceptance and treatment choice. The operator may recommend or execute a properly authorized decision but cannot unilaterally accept the business consequences.
C:Contractual delivery responsibility and technical expertise do not transfer the enterprise’s ultimate accountability for acceptance and treatment choice. The responsible internal authority must approve consequential decisions.
D:Independent assurance should test and challenge the acceptance and treatment choice decision, not ordinarily authorize the activity it will later evaluate. That would blur accountability and separation of duties.
Question 130
An approved response has slipped past its target date, and new business operations have changed the risk assumptions. An updated assessment raises concern that a sponsor could accept loss beyond delegated limits without evaluating practical treatment alternatives. Which response keeps the management decision current and accountable?
- Let the delivery team revise the acceptance and treatment choice response immediately and seek management ratification afterward.
- Have the delegated risk owner reassess acceptance and treatment choice and update the treatment decision to monitor response milestones and reopen decisions after material changes if new exposure exceeds tolerance.
- Report delivery of the existing acceptance and treatment choice plan without reopening the previous risk assumptions.
- Continue the approved acceptance and treatment choice exception until its original expiry, keeping the existing acceptance decision.
Explanation
Correct Answer
B:Exposure and residual acceptance depend on current assumptions. A delegated owner must reassess the new evidence because a sponsor could accept loss beyond delegated limits without evaluating practical treatment alternatives. The evidence needed to monitor response milestones and reopen decisions after material changes should be documented and escalated when the risk exceeds approved tolerance.
Incorrect Answers
A:Urgent actions may be allowed within predelegated incident authority, but unilateral changes by implementers do not replace accountable reassessment and escalation when business impact changes.
C:Historical approvals and task counts do not show that the changed risk remains within tolerance. The new condition warrants a refreshed analysis and accountable response, not solely activity reporting.
D:An exception record is not a substitute for assessing the significance of the new evidence to acceptance and treatment choice. Earlier acceptance was conditional on facts that may no longer hold.